DORV
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts (NCT04467671) | Nationwide Children's Hospital | 2020-07-15 |
Track DORV automatically
Every clearance here is in the API, with alerts when new ones post.